Search results
Sanofi Q1 Profit Weak, But Sales Rise; Backs FY24 View; Stock Up
RTT News· 5 days agoFrench drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi ...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoFind insight on Sanofi, AstraZeneca and more in the latest Market Talks covering the Health Care sector.
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoPublished exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0916 ET – Sanofi’s 1Q beat sales and profit expectations thanks to the...
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
KOLR - KSFX Ozarks· 5 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer ...
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks
Quartz· 5 days agoNovartis, Merck, Bristol-Myers Squibb, Biogen, AstraZeneca, and Sanofi all reported quarterly...
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Reuters· 5 days agoAbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron Pharmaceuticals and Sanofi's Dupixent in a late-stage head-to-head study.
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks· 6 days agoThe first-quarter 2024 reporting cycle of the Medical sector is about to pick up pace this week. The...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 5 days agoIn the V&I segment, AstraZeneca recorded $26 million as Beyfortus product sales from products...
Civil RICO Suit Accuses Big Pharma and Benefit Managers of Insulin Price-Fixing | Connecticut Law...
Law.com· 7 days agoIt filed the suit Monday in Connecticut federal court against Eli Lilly and Co., Novo Nordisk Inc., ...
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Reuters via AOL· 5 days agoRinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a...
